FDA Clearance Tracker · DEN240029
Healgen Rapid Check COVID-19/Flu A&B Antigen Test
Last checked: Nov 20, 2026Latest source record: Oct 7, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 7, 2024
De Novo granted
Time to decision
122 days
Received Jun 7, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN240029
- Device name
- Healgen Rapid Check COVID-19/Flu A&B Antigen Test
- Applicant
- Healgen
- Applicant location
- Houston, TX
- Received
- Jun 7, 2024
- Decided
- Oct 7, 2024
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3987
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN240029
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Healgen
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260095 · Decided Apr 13, 2026 · 90 days after receipt
Device type: Over-The-Counter Covid-19 Antigen Test (QYT) · Laboratory Medicine & Pathology
K253705 · Decided Mar 16, 2026 · 112 days after receipt
Device type: Thin Layer Chromatography, Methamphetamine (DJC) · Laboratory Medicine & Pathology
K252523 · Decided Feb 12, 2026 · 185 days after receipt
Device type: Test, Cannabinoid, Over The Counter (NFW) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.